Global Insulin Delivery Devices valued approximately USD 11.54 Billion in 2016 is anticipated to grow with healthy growth rate of more than 9.10% over the forecast period 2017-2025. The Key drivers in the market include Government support in specific countries, favorable reimbursement technological advancements in insulin delivery devices, and rising diabetic population.
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
§ Insulin syringes
§ Insulin pens
§ Insulin pumps
§ Insulin injectors
§ North America
§ Asia Pacific
§ Latin America
§ Rest of the World
Furthermore, the years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market are Novo Nordisk A/S, Sanofi, Eli Lilly and Company Biocon Ltd. Wockhardt Ltd and Medtronic. The companies are spending a lot on their research and development programs to keep up with the dynamically changing technologies in the market. Acquisitions and effective mergers are one of the expansion strategies taken by the key manufacturers.
Target Audience of the Insulin Delivery Devices Market Study
- § Key Consulting Companies & Advisors
§ Large, medium-sized, and small enterprises
§ Venture capitalists
§ Value-Added Resellers (VARs)
§ Third-party knowledge providers
§ Investment bankers
Please note that owing to the criticality of the Insulin Delivery Devices market and rapidly changing market attributes, we are in the middle of updating the report. The final report may require 2 to 3 working days post-confirmation in order to cater to the most recent updates.
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents:
Chapter 1. Research Methodology
1.1. Research Process
1.1.1. Data Mining
1.1.3. Market Estimation
1.2. Research Assumption
Chapter 2. Global Insulin Delivery Devices Market Definition & Scope
2.1. Objective of The Study
2.2. Market Definition
2.3. Scope of The Study
2.4. Years Considered for The Study
2.5. Currency Conversion Rates
2.6. Report Limitation
Chapter 3. Executive Summary
3.1. Key Trends
3.2. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)
Chapter 4. Global Insulin Delivery Devices Industry Dynamics
4.1. Growth Prospects
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novo Nordisk A/S
220.127.116.11. Financial (Subject to Data Availability)
18.104.22.168. Product Summary
22.214.171.124. Recent Developments
8.3.3. Eli Lilly and Company
8.3.4. Biocon Ltd.
8.3.5. Abbott Laboratories .
8.3.6. Wockhardt Ltd..
8.3.7. Becton, Dickinson and Company.
8.3.8. F. Hoffmann-La Roche, Ltd.
8.3.9. Tandem Diabetes Care, Inc.
8.3.10. Insulet Corporation.
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Phone: +1 646 845 9349, +44 208 133 9349